Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 NOK)

NET PROFIT (x1000 NOK)

EMPLOYEES

Share

Novakand Pharma AB

Closing information (x1000 NOK)

Closing information 2024/12 (consolidated) 2023/12 (consolidated) 2022/12 (consolidated)
Turnover 14 More Arrow 1,048 Less Arrow 712
Financial expenses 0 More Arrow 132 More Arrow 585
Earnings before taxes -45,961 Less Arrow -65,735 More Arrow -49,645
EBITDA -47,606 Less Arrow -65,890 More Arrow -48,785
Total assets 69,005 Less Arrow 66,498 More Arrow 114,208
Current assets 50,441 Less Arrow 48,263 More Arrow 94,109
Current liabilities 4,755 More Arrow 18,212 Less Arrow 13,078
Equity capital 64,250 Less Arrow 48,286 More Arrow 101,129
- share capital 12,147 Less Arrow 8,024 More Arrow 62,688
Employees (average) 5 Less Arrow 4 More Arrow 8

Financial ratios

Fiscal year 2024/12 (consolidated) 2023/12 (consolidated) 2022/12 (consolidated)
Solvency 93.1% Less Arrow 72.6% More Arrow 88.5%
Turnover per employee 3 More Arrow 262 Less Arrow 89
Profit as a percentage of turnover -328292.9% More Arrow -6272.4% Less Arrow -6972.6%
Return on assets (ROA) -66.6% Less Arrow -98.7% More Arrow -43.0%
Current ratio 1060.8% Less Arrow 265.0% More Arrow 719.6%
Return on equity (ROE) -71.5% Less Arrow -136.1% More Arrow -49.1%
Change turnover -1,053 More Arrow 286 Less Arrow -900
Change turnover % -99% More Arrow 37% Less Arrow -56%
Chg. No. of employees 1 Less Arrow -4 More Arrow 0
Chg. No. of employees % 25% Less Arrow -50% More Arrow 0%

Total value of public sale

Fiscal year 2024/12 (consolidated) 2023/12 (consolidated) 2022/12 (consolidated)
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.